Literature DB >> 19938214

The effect of tanshinone IIA on the cardiovascular system in ovine fetus in utero.

Caiping Mao1, Yifan Zhang, Yuying Zhang, Li Cao, Huan Shao, Liping Wang, Liyan Zhu, Zhice Xu.   

Abstract

This was the first study to determine the effect of tanshinone IIA (an active ingredient in herb Danshen) on fetuses in utero under unstressed condition. Tanshinone IIA or 0.9% NaCl as control was intravenously (i.v.) administrated into pregnant ewes. Both maternal and fetal blood were analyzed for PO(2), PCO(2), SO(2)%, hemoglobin, hemotecrit, glucose, lactic acid, Na(+), K(+), and Cl(-) concentrations. Maternal and fetal heart functions were assessed by examining cardiac enzymes and cardiovascular responses. The results showed that tanshinone IIA did not alter the blood values in ewes and fetuses. Cardiac enzyme activities related to the heart remained unchanged. In cardiovascular experiments, no alternation in maternal blood pressure by tanshinone IIA was observed. However, fetal systolic pressure was slightly and significantly increased following i.v. tanshinone IIA into the mothers, while fetal diastolic pressure, mean arterial pressure, and heart rate were not changed. The results demonstrated that tanshinone IIA used during the last third of gestation did not cause the biochemical changes related to cardiac functions in both maternal and fetal sheep. Fetal oxygen metabolism remained stable in utero, providing new information for clinical use of the herb in pregnancy. That tanshinone IIA increased fetal systolic pressure may open new opportunities to study the herb in fetal medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19938214     DOI: 10.1142/S0192415X09007478

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  The vascular effects of sodium tanshinone IIA sulphonate in rodent and human pregnancy.

Authors:  Jude S Morton; Irene J Andersson; Po-Yin Cheung; Philip Baker; Sandra T Davidge
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

2.  Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway.

Authors:  Shaowen Zhu; Wanfu Wei; Zhiwei Liu; Yang Yang; Haobo Jia
Journal:  Mol Med Rep       Date:  2018-03-14       Impact factor: 2.952

3.  Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR‑4‑mediated NF‑κB signal pathway.

Authors:  Chengzhi Fang; Lili Xie; Chunmei Liu; Chunhua Fu; Wei Ye; Hong Liu; Binghong Zhang
Journal:  Mol Med Rep       Date:  2018-06-26       Impact factor: 2.952

4.  Tanshinone‑IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes.

Authors:  Yeqing Fang; Chengcheng Duan; Shaoyuan Chen; Zhenguo Liu; Bimei Jiang; Wen Ai; Lei Wang; Peiyi Xie; Hongcheng Fang
Journal:  Int J Mol Med       Date:  2021-07-02       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.